False-Positive Galactomannan Results in Clinical Practice

Pharmaceutical Interferences

Piperacillin-tazobactam causes false-positive galactomannan in 58.3% of serum samples and 50% of BAL samples, making it a significant antibiotic interference to recognize 1, 2
Other β-lactam/β-lactamase combinations, including amoxicillin-clavulanate (26.7% serum false-positives), cefoperazone-sulbactam (66.7%), and carbapenems (45.5% BAL false-positives), also cause significant interference 2
Cross-reactivity with other organisms, including Histoplasma capsulatum and Penicillium species, can produce positive results 1, 3, 2

If galactomannan is positive in a patient, assess for symptoms such as fever, respiratory symptoms, or clinical deterioration, which suggest true invasive aspergillosis requiring immediate treatment 3
Check for piperacillin-tazobactam or other β-lactam antibiotics, and discontinue or switch if possible, as these are more likely culprits than micafungin 1, 3, 2
Obtain high-resolution chest CT immediately if symptomatic, as characteristic findings (halo sign, nodular lesions) confirm pulmonary aspergillosis 3
If symptomatic with positive galactomannan, initiate voriconazole immediately (6 mg/kg IV q12h × 24h, then 4 mg/kg IV q12h) without waiting for source identification, as this represents probable invasive aspergillosis 3

Anti-mold antifungal agents, such as voriconazole, posaconazole, and itraconazole, cause false-negative galactomannan results, reducing test sensitivity 1, 4, 2